Chemical Compound
Spironolactone Imp. F (EP); Spironolactone USP Related Compound A (AS); Spironolactone USP RC A (AS); (2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-; 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (6CI,7CI,8CI); Spiro[17H-cyclopenta[a]phenanthrene-17,2'(5'H)-furan], pregna-4,6-diene-21-carboxylic acid deriv.; 11614 R.P.; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid lactone; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone; 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone; 17beta-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid; 20-Spiroxa-4,6-diene-3,21-dione; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)propionic acid lactone; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)pr
CAS Registry Number
976-71-6
Primary record
Spironolactone Imp. F (EP); Spironolactone USP Related Compound A (AS); Spironolactone USP RC A (AS); (2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-; 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (6CI,7CI,8CI); Spiro[17H-cyclopenta[a]phenanthrene-17,2'(5'H)-furan], pregna-4,6-diene-21-carboxylic acid deriv.; 11614 R.P.; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid lactone; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone; 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone; 17beta-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid; 20-Spiroxa-4,6-diene-3,21-dione; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)propionic acid lactone; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)pr
- 库存
- 5,796 克
- 纯度
- 99.8 %
- CAS
- 976-71-6
化合物标识与属性
- CAS
- 976-71-6
- PubChem CID
- 13789
- SMILES
- C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C
- Canonical SMILES
- C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1
名称与同义词
- CANRENONE
- Aldadiene
- Phanurane
- Luvion
- Canrenona
- Canrenonum
- 976-71-6
- Aldadiene (VAN)
- Spiroletan
- Phanurane;
- Contaren;
- Canrenone CRS
- Luvion;
- Canrenone [USAN:INN]
- Canrenonum [INN-Latin]
- Canrenone (USAN)
- Canrenona [INN-Spanish]
- Canrenone (Standard)
- Spirolactone SC 14266
- Canrenone - 95%
- Spironolactone metabolite m1
- SC-9376
- CANRENONE [INN]
- CANRENONE [MI]
- DTXSID3045930
- CANRENONE [USAN]
- RefChem:123246
- Spironolactone Related Compound A
- Spironolactone EP impurity F
- Spirolactone SC-14266
- CANRENONE [MART.]
- C22H28O3
- UNII-78O20X9J0U
- AC1L22HH
- CANRENONE [WHO-DD]
- UJVLDDZCTMKXJK-WNHSNXHDSA-N
- 78O20X9J0U
- SC 9376
- MFCD00071735
- SCHEMBL19560
- DTXCID1025930
- MLS001163777
- MLS001304014
- MLS001304154
- Canrenone - Bio-X trade mark
- EINECS 213-554-5
- SC9376
- orb1310694
- orb3025819
- Canrenone, >=97% (HPLC)
- CHEMBL1463345
- NSC 261713
- NSC-261713
- ERK5-3K04
- GTPL13963
- HY-B1438R
- BRN 0046602
- Aldadiene;SC9376;SC14266
- CHEBI:135445
- HMS2090K21
- HMS2870D16
- HMS3715A05
- RP 11641
- BCP10925
- CID13789
- HY-B1438
- ZINC3881648
- 11614 R.P
- Tox21_111451
- (17a)-17-Hydroxy-3-oxopregna-4
- BBL010921
- CID:13789
- EBC-13716
- s5273
- STK801874
- 20-Spiroxa-4,6-diene-3,21-dione
- AKOS005622473
- Tox21_111451_1
- 6-diene-21-carboxylic acid ?-lactone
- AC-1323
- C22-H28-O3
- CCG-220962
- CS-O-01197
- DB12221
- FC19670
- J7.205B
- MSK000847-100A
- NE40132
- MSK000847-1000A
- NCGC00095148-01
- NCGC00263479-01
- NCGC00263479-02
- NCGC00263479-06
- 11614 R. P.
- AJ-46645
- AK-77478
- AS-13160
- BC300044
- CAS-976-71-6
- FC166171
- H489
- R.P., 11614
- SC-15111
- SMR000539206
- EC 213-554-5
- SID:134224165
- 11614R.P.
- AB0013073
- LS-118413
- 11614 R. P
- 11614 R.P.
- B7341
- CS-0013142
- NS00010904
- 5-17-11-00476 (Beilstein Handbook Reference)
- Canrenone Solution in Acetonitrile, 100ug/mL
- Canrenone Solution in Acetonitrile, 1000ug/mL
- D03363
- D95826
- EN300-123063
- J10438
- SPIRONOLACTONE IMPURITY F [EP IMPURITY]
- (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
- AB00825212-04
- AB00825212-06
- 976C716
- A845738
- D002192
- SPIRONOLACTONE RELATED COMPOUND A [USP-RS]
- SR-01000813823
- 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone
- Q5033475
- SR-01000813823-2
- 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone
- 17b-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, g-lactone,(17a)-
- Z1546624239
- Canrenone, European Pharmacopoeia (EP) Reference Standard
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (17alpha)-
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-
- (1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-6',8'-diene-5,5'-dione
- (10R,13S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
- Eplerenone Impurity - Canrenone; Spironolactone EP Impurity F
- 17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid lactone
- 17|A-2-Carboxyethyl-17|A-hydroxyandrosta-4,6-dien-3-one Lactone
- 17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one lactone
- 17a-2-Carboxyethyl-17b-hydroxyandrosta-4,6-dien-3-one lacton e
- 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone
- (17?)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid ?-lactone
- (17|A)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic Acid |A-Lactone
- (17R)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid gamma-lactone
- (17R)-3-Oxo-17-hydroxypregna-4,6-diene-21-carboxylic acid gamma-lactone
- (1R,3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-2,3,3a,3b,7,8,9,9a,9b,10,11,11a-dodecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7-dione
- (2'R,8R,9S,10R,13S,14S)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione
- (7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic acid gamma-lactone
- 17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid g-lactone
- 17-hydroxy-3-oxo-17a-pregna-4,6-diene-21-carboxylic acid gamma-lactone
- 3'-(3-Oxo-17b-hydroxyandrosta-4,6-dien-17a-yl)-propionic acid lactone
- 3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid g-lactone
- 3-(17b-Hydroxy-3-oxoandrosta-4,6-dien-17a-yl)propionic acid lactone
- 3-(3-Oxo-17b-hydroxy-4,6-androstadien-17a-yl)propionic acid g-lactone
- (17-alpha)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid gamma-lactone
- 17.alpha.-(2-Carboxyethyl)-17.beta.-hydroxyandrosta-4,6-dien-3-one lactone
- 17.alpha.-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, .gamma.-lactone
- 2R)-3,4-DIHYDRO-5H-SPIRO(ANDROST-4,6-DIENE-17,2-FURAN)-3,5-DIONE
- 3',4'-Dihydrospiro[androst-4,6-diene-17,2'(5'H)-furan]-3,5'-dione (Canrenone)
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, .gamma.-lactone (17.alpha.)-
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, .gamma.-lactone, (17.alpha.)-
- Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17-alpha)-
- Spironolactone Related Compound A, United States Pharmacopeia (USP) Reference Standard
- (1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro(oxolane-2,14'-tetracyclo(8.7.0.0^(2,7).0^(11,15))heptadecane)-6',8'-diene-5,5'-dione
- (1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0?,?.0??,??]heptadecane]-6',8'-diene-5,5'-dione
- (1R,3aS,3bR,9aR,9bS,11aS)-9a,11a-Dimethyl-2,3,3a,8,9,9a,9b,10,11,11a-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7(3bH)-dione
- (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,3',4',8,9,10,11,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione
- (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione
- (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-tetrahydrofuran]-2',3-dione
- 154738-42-8
- 213-554-5
- Spironolactone Imp. F (EP); Spironolactone USP Related Compound A (AS); Spironolactone USP RC A (AS); (2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-; 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (6CI,7CI,8CI); Spiro[17H-cyclopenta[a]phenanthrene-17,2'(5'H)-furan], pregna-4,6-diene-21-carboxylic acid deriv.; 11614 R.P.; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid lactone; 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone; 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone; 17beta-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid; 20-Spiroxa-4,6-diene-3,21-dione; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)propionic acid lactone; 3-(17beta-Hydroxy-3-oxoandrosta-4,6-dien-17alpha-yl)pr